Evidence map›Paper›PMID 27624948›Full record

ArticleJournal of oncology practice2016

Resolving Rivalries and Realigning Goals: Challenges of Clinical and Research Multiteam Systems.

David E Gerber, Torsten Reimer, Erin L Williams, Mary Gill, Laurin Loudat Priddy, Deidi Bergestuen, Joan H Schiller, Haskell Kirkpatrick, Simon J Craddock Lee

Abstract readCase Reports
In one paragraph

Article in Journal of oncology practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Multidisciplinary clinician perspectives on avoidable emergency department use by patients during cancer treatment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David E GerberUniversity of Texas Southwestern Medical Center and Texas Oncology, Dallas, TX; and Purdue University, West Lafayette, IN.
Torsten ReimerUniversity of Texas Southwestern Medical Center and Texas Oncology, Dallas, TX; and Purdue University, West Lafayette, IN.
Erin L WilliamsUniversity of Texas Southwestern Medical Center and Texas Oncology, Dallas, TX; and Purdue University, West Lafayette, IN.
Mary GillUniversity of Texas Southwestern Medical Center and Texas Oncology, Dallas, TX; and Purdue University, West Lafayette, IN.
Laurin Loudat PriddyUniversity of Texas Southwestern Medical Center and Texas Oncology, Dallas, TX; and Purdue University, West Lafayette, IN.
Deidi BergestuenUniversity of Texas Southwestern Medical Center and Texas Oncology, Dallas, TX; and Purdue University, West Lafayette, IN.
Joan H SchillerUniversity of Texas Southwestern Medical Center and Texas Oncology, Dallas, TX; and Purdue University, West Lafayette, IN.
Haskell KirkpatrickUniversity of Texas Southwestern Medical Center and Texas Oncology, Dallas, TX; and Purdue University, West Lafayette, IN.
Simon J Craddock LeeUniversity of Texas Southwestern Medical Center and Texas Oncology, Dallas, TX; and Purdue University, West Lafayette, IN.

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
UT Southwestern Center of Patient-Centered Outcomes Research (PCOR)R24HS022418 · AHRQ · UT SOUTHWESTERN MEDICAL CENTER · PI HALM, ETHAN A · 2013 to 2017
$5.0M
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10U10CA180870 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GERBER, DAVID ERIC · 2014 to 2018
$3.4M
Development of New Cancer Treatments and InvestigatorsK24CA201543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GERBER, DAVID ERIC · 2016 to 2020
$737k
AHRQ HHS R24 HS022418NCI NIH HHS K24 CA201543NCI NIH HHS P30 CA142543NCI NIH HHS U10 CA180870
6 · The paper itself

Abstract

This article describes the care processes for a 64-year-old man with newly diagnosed advanced non-small-cell lung cancer who was enrolled in a first-line clinical trial of a new immunotherapy regimen. The case highlights the concept of multiteam systems in cancer clinical research and clinical care. Because clinical research represents a highly dynamic entity-with studies frequently opening, closing, and undergoing modifications-concerted efforts of multiple teams are needed to respond to these changes while continuing to provide consistent, high-level care and timely, accurate clinical data. The case illustrates typical challenges of multiteam care processes. Compared with clinical tasks that are routinely performed by single teams, multiple-team care greatly increases the demands for communication, collaboration, cohesion, and coordination among team members. As the case illustrates, the described research team and clinical team are separated, resulting in suboptimal function. Individual team members interact predominantly with members of their own team. A considerable number of team members lack regular interaction with anyone outside their team. Accompanying this separation, the teams enact rivalries that impede collaboration. The teams have misaligned goals and competing priorities that create competition. Collective identity and cohesion across the two teams are low. Research team and clinical team members have limited knowledge of the roles and work of individuals outside their team. Recommendations to increase trust and collaboration are provided. Clinical providers and researchers may incorporate these themes into development and evaluation of multiteam systems, multidisciplinary teams, and cross-functional teams within their own institutions.

Indexed as

Attitude of Health PersonnelCooperative BehaviorCarcinoma, Non-Small-Cell LungHumansLung NeoplasmsMaleMiddle AgedPatient Care TeamRandomized Controlled Trials as Topic

Identifiers

PMID27624948
PMCPMC5455413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.